ID

11999

Beschrijving

Efficacy and Safety of Empagliflozin Versus Sitagliptin in Patients With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01984606

Link

https://clinicaltrials.gov/show/NCT01984606

Trefwoorden

  1. 31.08.15 31.08.15 -
Houder van rechten

ODM derived from: https://clinicaltrials.gov/show/NCT01984606

Geüploaded op

31. August 2015

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Diabetes Mellitus, Type 2 NCT01984606

Eligibility Diabetes Mellitus, Type 2 NCT01984606

Inclusion Criteria
Beschrijving

Inclusion Criteria

Inclusion Criteria
Beschrijving

Inclusion Criteria

diagnosis of type 2 diabetes mellitus.
Beschrijving

diabetes mellitus; type 2 diabetes; diagnosis

Datatype

boolean

Alias
UMLS CUI [1]
C0011860
male and female patients on diet and exercise regimen who are:
Beschrijving

exercise; regimen; female; diet

Datatype

boolean

Alias
UMLS CUI [1]
C0682069
treatment-naïve, defined as absence of any oral antidiabetic therapy for 12 weeks prior to randomisation.
Beschrijving

treatment; therapy; oral

Datatype

boolean

Alias
UMLS CUI [1]
C0039798
pre-treated with immediate release metformin unchanged for 10 weeks prior to randomisation. minimum dose for metformin: >=1500 mg/day or maximum tolerated dose or maximum dose according to local label.
Beschrijving

metformin; local; dose; day

Datatype

boolean

Alias
UMLS CUI [1]
C0025598
hba1c of >= 7.5 % and <= 10.5 % at visit 1 and 3.
Beschrijving

visit; hba1c

Datatype

boolean

Alias
UMLS CUI [1]
C0019018
age >= 18 yrs.
Beschrijving

age

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
Exclusion Criteria
Beschrijving

Exclusion Criteria

uncontrolled hyperglycaemia with a glucose level >270 mg/dl (>15 mmol/l) after an overnight fast during dose stabilisation (if applicable) and/or placebo run-in.
Beschrijving

glucose; mmol/l; dose

Datatype

boolean

Alias
UMLS CUI [1]
C0020456
any other antidiabetic drug within 12 weeks prior to randomisation (applicable to treatment-naïve patients).
Beschrijving

treatment; other; drug

Datatype

boolean

Alias
UMLS CUI [1]
C0935929
any other antidiabetic drug within 10 weeks prior to randomisation except metformin (applicable to patients on background treatment with metformin).
Beschrijving

treatment; metformin; other; drug

Datatype

boolean

Alias
UMLS CUI [1]
C0935929
acute coronary syndrome (non-stemi, stemi and unstable angina pectoris), stroke or tia within 3 months prior to informed consent.
Beschrijving

acute coronary syndrome; informed consent; unstable angina; angina pectoris; stroke; stemi; non

Datatype

boolean

Alias
UMLS CUI [1]
C0948089
indication of liver disease.
Beschrijving

liver disease; indication

Datatype

boolean

Alias
UMLS CUI [1]
C0023895
moderate to severe renal impairment.
Beschrijving

impairment; moderate; severe; renal

Datatype

boolean

Alias
UMLS CUI [1]
C1565489
bariatric surgery within the past two years.
Beschrijving

surgery

Datatype

boolean

Alias
UMLS CUI [1]
C1456587
treatment with anti-obesity drugs 3 months prior to informed consent.
Beschrijving

informed consent; treatment; obesity; drugs

Datatype

boolean

Alias
UMLS CUI [1]
C0376607
current treatment with systemic steroids at time of informed consent or any other uncontrolled endocrine disorder except type 2 diabetes mellitus.
Beschrijving

diabetes mellitus; informed consent; type 2 diabetes; treatment; steroids; disorder; other; systemic; current; time

Datatype

boolean

Alias
UMLS CUI [1]
C2825233
UMLS CUI [2]
C0014130

Similar models

Eligibility Diabetes Mellitus, Type 2 NCT01984606

Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
diabetes mellitus; type 2 diabetes; diagnosis
Item
diagnosis of type 2 diabetes mellitus.
boolean
C0011860 (UMLS CUI [1])
exercise; regimen; female; diet
Item
male and female patients on diet and exercise regimen who are:
boolean
C0682069 (UMLS CUI [1])
treatment; therapy; oral
Item
treatment-naïve, defined as absence of any oral antidiabetic therapy for 12 weeks prior to randomisation.
boolean
C0039798 (UMLS CUI [1])
metformin; local; dose; day
Item
pre-treated with immediate release metformin unchanged for 10 weeks prior to randomisation. minimum dose for metformin: >=1500 mg/day or maximum tolerated dose or maximum dose according to local label.
boolean
C0025598 (UMLS CUI [1])
visit; hba1c
Item
hba1c of >= 7.5 % and <= 10.5 % at visit 1 and 3.
boolean
C0019018 (UMLS CUI [1])
age
Item
age >= 18 yrs.
boolean
C0001779 (UMLS CUI [1])
glucose; mmol/l; dose
Item
uncontrolled hyperglycaemia with a glucose level >270 mg/dl (>15 mmol/l) after an overnight fast during dose stabilisation (if applicable) and/or placebo run-in.
boolean
C0020456 (UMLS CUI [1])
treatment; other; drug
Item
any other antidiabetic drug within 12 weeks prior to randomisation (applicable to treatment-naïve patients).
boolean
C0935929 (UMLS CUI [1])
treatment; metformin; other; drug
Item
any other antidiabetic drug within 10 weeks prior to randomisation except metformin (applicable to patients on background treatment with metformin).
boolean
C0935929 (UMLS CUI [1])
acute coronary syndrome; informed consent; unstable angina; angina pectoris; stroke; stemi; non
Item
acute coronary syndrome (non-stemi, stemi and unstable angina pectoris), stroke or tia within 3 months prior to informed consent.
boolean
C0948089 (UMLS CUI [1])
liver disease; indication
Item
indication of liver disease.
boolean
C0023895 (UMLS CUI [1])
impairment; moderate; severe; renal
Item
moderate to severe renal impairment.
boolean
C1565489 (UMLS CUI [1])
surgery
Item
bariatric surgery within the past two years.
boolean
C1456587 (UMLS CUI [1])
informed consent; treatment; obesity; drugs
Item
treatment with anti-obesity drugs 3 months prior to informed consent.
boolean
C0376607 (UMLS CUI [1])
diabetes mellitus; informed consent; type 2 diabetes; treatment; steroids; disorder; other; systemic; current; time
Item
current treatment with systemic steroids at time of informed consent or any other uncontrolled endocrine disorder except type 2 diabetes mellitus.
boolean
C2825233 (UMLS CUI [1])
C0014130 (UMLS CUI [2])

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial